Business Segments · Selling and administrative expense
Medical — Selling and administrative expense
Becton, Dickinson and Company Medical — Selling and administrative expense decreased by 12.9% to $1.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.6%, from $1.12B to $1.21B. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ3 2013
Last reportedQ1 2026
Rolls up toSG&A
How to read this metric
Rising expenses may indicate investment in sales growth, while excessive growth relative to revenue could signal administrative bloat.
Detailed definition
Includes the indirect costs of operating the medical segment, such as sales force compensation, marketing, and general a...
Peer comparison
Standard SG&A expense reporting for business units in large diversified healthcare companies.
Metric ID:
bdx_segment_medical_selling_and_administrative_expenseHistorical Data
32 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q4 '22 | Q1 '23 | Q1 '23 | Q2 '23 | Q2 '23 | Q3 '23 | Q3 '23 | Q4 '23 | Q4 '23 | Q1 '24 | Q1 '24 | Q2 '24 | Q2 '24 | Q3 '24 | Q3 '24 | Q4 '24 | Q4 '24 | Q1 '25 | Q1 '25 | Q2 '25 | Q2 '25 | Q3 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.20B | $1.22B | $1.19B | $1.19B | $1.15B | $1.18B | $1.19B | $248.25M | $1.21B | $248.25M | $1.19B | $248.25M | $1.14B | $248.25M | $1.21B | $257.75M | $1.19B | $257.75M | $1.20B | $257.75M | $1.26B | $257.75M | $1.32B | $328.00M | $1.12B | $328.00M | $1.32B | $328.00M | $1.52B | $328.00M | $1.39B | $1.21B |
| QoQ Change | — | +1.8% | -3.0% | +0.6% | -3.6% | +3.0% | +0.3% | -79.1% | +385.4% | -79.4% | +379.4% | -79.1% | +358.0% | -78.2% | +388.6% | -78.8% | +362.9% | -78.4% | +364.0% | -78.4% | +386.9% | -79.5% | +411.3% | -75.1% | +240.5% | -70.6% | +302.4% | -75.2% | +364.3% | -78.5% | +324.7% | -12.9% |
| YoY Change | — | — | — | — | -4.3% | -3.2% | +0.2% | -79.1% | +1.1% | -79.2% | +3.6% | -78.4% | -3.9% | -79.0% | +2.2% | -78.3% | -1.0% | -78.6% | +0.5% | -78.3% | +10.4% | -77.3% | +8.7% | -73.0% | -6.4% | -72.5% | +10.4% | -72.6% | +21.4% | -73.9% | +5.7% | +8.6% |
Range$248.25M – $1.52B
CAGR+0.1%
Avg YoY Growth-30.9%
Median YoY Growth-4.1%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Becton, Dickinson and Company's medical — selling and administrative expense?
- Becton, Dickinson and Company (BDX) reported medical — selling and administrative expense of $1.21B in Q1 2026.
- How has Becton, Dickinson and Company's medical — selling and administrative expense changed year-over-year?
- Becton, Dickinson and Company's medical — selling and administrative expense increased by 8.6% year-over-year, from $1.12B to $1.21B.
- What does medical — selling and administrative expense mean?
- Total indirect costs for selling and managing the medical business segment.